NCT04276987View on ClinicalTrials.gov

A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

May 31, 2020

Study Completion Date

July 31, 2020

Conditions
Coronavirus
Interventions
BIOLOGICAL

MSCs-derived exosomes

5 times aerosol inhalation of MSCs-derived exosomes (2.0\*10E8 nano vesicles/3 ml at Day 1, Day 2, Day 3, Day 4, Day 5).

Trial Locations (1)

200025

Ruijin Hospital Shanghai Jiao Tong University School of Medicine, Shanghai

All Listed Sponsors
collaborator

Shanghai Public Health Clinical Center

OTHER_GOV

collaborator

Wuhan Jinyintan Hospital, Wuhan, China

UNKNOWN

collaborator

Shanghai AbelZeta Ltd.

INDUSTRY

lead

Ruijin Hospital

OTHER

NCT04276987 - A Pilot Clinical Study on Inhalation of Mesenchymal Stem Cells Exosomes Treating Severe Novel Coronavirus Pneumonia | Biotech Hunter | Biotech Hunter